Comments on: Boehringer Ingelheim Licenses ProBioGen’s Novel GlymaxX® Technology /contractors/contract-manufacturers/boehringer-2/pressreleases/press3-57/ The leading site for news and procurement in the pharmaceutical industry Tue, 09 Aug 2011 17:30:00 +0000 hourly 1 https://wordpress.org/?v=6.7.2